2
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 2
1
Status
Unknown
1
Recruiting
1
Sponsor Class
UNKNOWN
1
INDUSTRY
1
Study Type
Interventional
2
Sponsor
Cancer Type
Thoracic
1
Head & Neck
1
Conditions
Carcinoma, Non-Small-Cell Lung
35
Lung Neoplasms
7
Squamous Cell Carcinoma of Head and Neck
5
Ovarian Neoplasms
5
Esophageal Neoplasms
5
Uterine Cervical Neoplasms
2
Stomach Neoplasms
2
Small Cell Lung Carcinoma
2
Retinoblastoma
2
Resectable Non-small Cell Lung Cancer
2
Neoplasms
2
Neoplasm Metastasis
2
Urinary Bladder Neoplasms
1
Squamous-Cell Lung Cancer
1
Sjogren's Syndrome
1
Scleroderma, Systemic
1
Retinal Neoplasms
1
Resectable Stage II-III Non-Small Cell Lung Cancer (NSCLC)
1
Resectable Lung Non-Small Cell Carcinoma
1
Recurrence
1
Psoriasis
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Pancreatic Neoplasms
1
Ovarian Cancer Recurrent
1
Oropharyngeal Neoplasms
1
Nonsquamous Non-small Cell Lung Cancer
1
Non-Squamous Non-Small Cell Lung Cancer
1
NSCLC
1
Multiple Sclerosis
1
Melanoma
1
Interventions
pembrolizumab
156
Gemcitabine
140
Capecitabine
123
Paclitaxel
120
Fluorouracil
117
Oxaliplatin
110
Bevacizumab
106
Nivolumab
99
Leucovorin
97
Docetaxel
97
Cisplatin
89
Radiosurgery
88
Irinotecan
87
Carboplatin
85
Cetuximab
72
Cyclophosphamide
71
Magnetic Resonance Spectroscopy
68
Specimen Handling
60
Radiotherapy
60
Trastuzumab
59
Biopsy
59
Ipilimumab
53
Drug Therapy
51
Everolimus
48
Pemetrexed
46
Albumin-Bound Paclitaxel
45
130-nm albumin-bound paclitaxel
44
Doxorubicin
42
Fulvestrant
40
aldesleukin
37
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Neoplasm Metastasis
×
Platinum Compounds
×
Clear all
NCT06216301
2025-12-17
LUNAR-2
NovoCure Ltd.
Phase 3
Recruiting
734 enrolled
NCT05136768
2021-11-29
LM-HNSCC
ChineseAMS
Phase 2
Unknown
50 enrolled